Featured Video Play Icon

AET Laboratories 20th anniversary celebration

Last year, we not only celebrated Tiefenbacher Group´s  60th anniversary in Hamburg, but also the 20th anniversary of AET Laboratories – our development and manufacturing site in Hyderabad, India.

AET Laboratories 20th anniversary celebration was a tremendous success!

Before the end-of-year celebrations, some games like cricket, badminton, lemon spoon, tennis kite etc. were conducted for all employees to participate in.
The management also distributed sportswear and shoes to around 80 students of the school sponsored by Tiefenbacher Group. As a grand finale, AET Labs’ 20th birthday was celebrated with cultural activities such as dancing, singing, skits, and distribution of prizes to the winners of various sports.

Thank you to everyone who made this wonderful event possible. You made this celebration very special and created a unique atmosphere in which our so-called “Tifi spirit” came alive.

Tiefenbacher Pharmaceuticals, a part of Tiefenbacher Group, develops and commercializes generic, value added, and innovative pharmaceuticals as well as medical devices worldwide. We provide over 180+ pharmaceutical products across various therapeutic categories in 10+ dosage forms. With our in-house product development and manufacturing, we can address specific therapeutic needs in unique formulations of prescription drugs (Rx) and over-the-counter (OTC) medicines for global markets (including highly potent drugs).

For more information about our finished dosage forms and healthcare solutions, please contact Tiefenbacher Pharmaceuticals: info@tiefenbacher.com or visit us on: www.tiefenbacher-pharmaceuticals.com


Featured Video Play Icon

Tiefenbacher Pharmaceuticals wishes you a happy new year!

TIEFENBACHER PHARMACEUTICALS, a part of TIEFENBACHER GROUP: As 2023 draws to a close, we would like to share some of the year's highlights with you.

This year we not only had our 60th anniversary to celebrate, but also many other great events:

In addition to several international generic launches we have successfully prepared the launch of the antihistamine Bilastine for a market entry as over-the-counter medicine in Germany. Furthermore we presented our innovative healthcare brand OYSTA in collaboration with OnDosis and inaugurated our new development block “Alfred” for highly potent drugs in Hyderabad, India.

Additionally we defined our sustainability goals for the future and started to implement them by installing solar panels at our site in Cyprus, replanting trees on building land in India, and setting up e-bike stations at our headquarters. Our social projects have not been neglected either, we have built a school in India, our employees have spent their social day in charitable institutions in Hamburg and our team has collected donations for charity.

This year we have been to numerous fairs and events to meet you in person and tell you about our latest product portfolio and how we make pharmaceuticals more affordable, more available, and better than before!

All in all we hope the year 2024 will be as successful and full of unique moments as the past one and we are looking forward to meeting you again in person all over the world!

TIEFENBACHER PHARMACEUTICALS, a part of Tiefenbacher Group, develops and commercializes genericvalue added, and innovative pharmaceuticals as well as medical devices and e-health solutions worldwide. We provide over 180+ pharmaceutical products across various therapeutic categories in 10+ dosage forms. With our in-house product development and manufacturing, we can address specific therapeutic needs in unique formulations of prescription drugs (Rx) and over-the-counter (OTC) medicines for global markets (including highly potent drugs).
For more information about our finished dosage forms and healthcare solutions, please contact Tiefenbacher Pharmaceuticals: info@tiefenbacher.com or visit us on: www.tiefenbacher-pharmaceuticals.com


Tiefenbacher New Market Launch: Rivaroxaban in Canada

Tiefenbacher Pharmaceuticals successfully launches the anticoagulant Rivaroxaban on day one in Canada

We at Tiefenbacher Pharmaceuticals strongly believe that our high-quality medicines should be affordable and available for all patients around the world. A key point here is that this applies to everyone, regardless of their nationality or income. That´s why we are thrilled to share that we have successfully prepared a day one launch of the generic version of the anticoagulant Rivaroxaban in Canada.

Generics are therapeutically equivalent to their branded counterparts with a lower price due to losing patent protection. The low cost of generic medications promotes patient affordability and contributes to lower per capita healthcare spending.

Rivaroxaban is an anticoagulant medication (blood thinner) used to treat and prevent blood clots. It makes blood flow through veins more easily by stopping a clotting factor called factor Xa from working. Rivaroxaban is also used to reduces the risk of stroke and systemic embolism with nonvalvular atrial fibrillation. The tablets are marketed in the strengths 2.5mg (for the very first time), 10mg, 15mg, and 20mg by our cooperation partner.

The product has been developed in TIEFENBACHER GROUP´s own laboratories in Hyderabad, India. Also it has already been launched in several European and international markets before. Overall, Tiefenbacher country scope covers about 70 countries around the world. Furthermore, the successful launch of this anticoagulant is a testament to the hard work and dedication of the team.

Finally, we are particularly excited about the positive impact of the launch of rivaroxaban. Look forward to further market entries with high-quality medicines – with a patient-centred approach for better healthcare.

TIEFENBACHER PHARMACEUTICALS, a part of Tiefenbacher Group, develops and commercializes generic, value added, and innovative pharmaceuticals as well as medical devices and e-health-solutions worldwide. We provide over 180+ pharmaceutical products across various therapeutic categories in 10+ dosage forms. With our in-house product development and manufacturing, we can address specific therapeutic needs in unique formulations of prescription drugs (Rx) and over-the-counter (OTC) medicines for global markets.  

For more information about our finished dosage forms (FDF) including highly potent drugs and e-healthcare solutions, please contact us at  info@tiefenbacher.com or visit us on  www.tiefenbacher-pharmaceuticals.com

About Tiefenbacher Group – Pioneering Healthcare since 1963

Tiefenbacher Group is a purpose-driven and 100% family-owned healthcare company providing best-in-class solutions along the entire pharmaceutical value chain. From the initial idea to market access of high-quality medicines around the world: We distribute APIs and develop, produce, and register finished dosage forms (FDFs) including highly potent drugs as well as medical devices and e-health solutions. The purpose is to improve people’s lives by making pharmaceuticals more affordable, more available, and better than ever before.

For further information about TIEFENBACHER GROUP and our solutions for better healthcare and our in-house capabilities to develop and commercialize pharmaceutical products for global markets (including highly potent drugs) please contact us by email at info@tiefenbacher.com or visit us on:  www.tiefenbachergroup.com


Featured Video Play Icon

Tiefenbacher Pharmaceuticals at CPhI Barcelona 2023

Tiefenbacher Pharmaceuticals, a part of Tiefenbacher Group, at CPHI Barcelona 2023

We are pleased to say that we have had three very successful days full of inspiring meetings CPHI Barcelona 2023. A big thanks to all who visited us in Barcelona. It was wonderful to meet many familiar and new faces and we are already looking forward to seeing you again next year in Milan!

Thank you to our colleagues from our three main locations in Hamburg (Germany), Hyderabad (India) and Lefkosia (Cyprus) for making this expo so special.

The Tiefenbacher Group participated in the CPhI, the world’s leading event for the pharmaceutical industry, from October 24 to 26 in Barcelona! Where visitors could explore the new booth of Tiefenbacher and discover our latest product portfolio and innovations in the field of raw materials, finished dosage forms, and medical devices! This was the opportunity to get in touch with many of our experts to discuss new business opportunities and ideas for making pharmaceuticals more affordable, more available, and better than before!

TIEFENBACHER PHARMACEUTICALS, a part of Tiefenbacher Group, develops and commercializes genericvalue added, and innovative pharmaceuticals as well as medical devices and e-health solutions worldwide. We provide over 180+ pharmaceutical products across various therapeutic categories in 10+ dosage forms. With our in-house product development and manufacturing, we can address specific therapeutic needs in unique formulations of prescription drugs (Rx) and over-the-counter (OTC) medicines for global markets.
For more information about our finished dosage forms (FDF) including highly potent drugs and healthcare solutions, please contact Tiefenbacher Pharmaceuticals: info@tiefenbacher.com or visit us on: www.tiefenbacher-pharmaceuticals.com


Featured Video Play Icon

60 years of pioneering healthcare at Tiefenbacher Group! 

Tiefenbacher Pharamaceuticals – a part of Tiefenfacher Group:
60 years of Pioneering Healthcare

Tiefenbacher Group says “Thank you” to our colleagues from our three main locations in Hamburg (Germany), Hyderabad (India) and Lefkosia (Cyprus) for sharing their short 60-year anniversary greetings in their respective national languages with you.

We are proud to have a team of 26 different nationalities and believe that a diverse team brings a wealth of perspectives, experiences and ideas that drive innovation and success in pioneering healthcare. It is unbelievable to have so many talented and outstanding employees in our group! With the curiosity and commitment of our employees we will continue to make medicines better affordable, better available, and better than before!

TIEFENBACHER PHARMACEUTICALS, a part of Tiefenbacher Group, develops and commercializes genericvalue added, and innovative pharmaceuticals as well as medical devices and e-health solutions worldwide. We provide over 180+ pharmaceutical products across various therapeutic categories in 10+ dosage forms. With our in-house product development and manufacturing, we can address specific therapeutic needs in unique formulations of prescription drugs (Rx) and over-the-counter (OTC) medicines for global markets.
For more information about our finished dosage forms (FDF) including highly potent drugs and healthcare solutions, please contact Tiefenbacher Pharmaceuticals: info@tiefenbacher.com or visit us on: www.tiefenbacher-pharmaceuticals.com


Featured Video Play Icon

Tiefenbacher Group 60 years anniversary celebration!

Tiefenbacher Pharamaceuticals – a part of Tiefenfacher Group:
60 years anniversary celebrations

We are very happy to announce that Tiefenbacher Group celebrates its 60th anniversary this year!

60 years ago, our founder and pioneer Alfred E. Tiefenbacher started our pharmaceutical business in Germany. 30 years later, we became an European company and today, 60 years later, we are a globally operating healthcare company which improves patients´ lives around the world. Since our founding, we have always been driven by our purpose to make pharmaceuticals better affordable, better available, and better than before!

Watch our three managing directors from our headquarters in Hamburg Dr. Kristian Ruepp, Oliver Schrader, and Frank Tettinger in our short video answering 3 central questions about Tiefenbacher Group!

TIEFENBACHER PHARMACEUTICALS, a part of Tiefenbacher Group, develops and commercializes genericvalue added, and innovative pharmaceuticals as well as medical devices and e-health solutions worldwide. We provide over 180+ pharmaceutical products across various therapeutic categories in 10+ dosage forms. With our in-house product development and manufacturing, we can address specific therapeutic needs in unique formulations of prescription drugs (Rx) and over-the-counter (OTC) medicines for global markets.
For more information about our finished dosage forms (FDF) including highly potent drugs and healthcare solutions, please contact Tiefenbacher Pharmaceuticals: info@tiefenbacher.com or visit us on: www.tiefenbacher-pharmaceuticals.com


launch of generic Teriflunomide Multiple Sclerosis (MS)

Tiefenbacher Pharmaceuticals launch of generic Teriflunomide

New market launch by Tiefenbacher Pharmaceuticals: Generic version of Teriflunomide in more than 20 European countries.

We are thrilled to announce that we have successfully prepared a day one launch of the generic version of Multiple Sclerosis (MS) medication Teriflunomide (reference brand name: Aubagio).

This complex generic launch follows Tiefenbacher`s strategy to make high quality pharmaceuticals better affordable and better available for patients worldwide. Generics are therapeutically equivalent to their branded counterparts with a lower price due to losing patent protection. The low cost of generic medications promotes patient affordability and contributes to lower per capita healthcare spending.

Basically, Teriflunomide is used to treat Multiple Sclerosis (MS) – a chronic disease that effects the central nervous system. The 14 mg film coated tablets developed and produced in Tiefenbacher Group`s own sites. Following this, the finished product is marketed by our partners, renowned international pharmaceutical companies. The product has already been successfully launched in the US, Canada, Mexico, and Australia – all with strict US Food and Drug Administration (FDA) standards.

Further markets will follow shortly to increase the global availability of our high-quality generic medicines even more. Tiefenbacher Group continuously making high-quality medicines better affordable, better global availability, and better than before.

TIEFENBACHER PHARMACEUTICALS, a part of Tiefenbacher Group, develops and commercializes generic, value added, and innovative pharmaceuticals as well as medical devices and e-health solutions worldwide. We provide over 180+ pharmaceutical products across various therapeutic categories in 10+ dosage forms. With our in-house product development and manufacturing, we can address specific therapeutic needs in unique formulations of prescription drugs (Rx) and over-the-counter (OTC) medicines for global markets.

For more information about our finished dosage forms (FDF) including highly potent drugs and e-health solutions, please contact Tiefenbacher Pharmaceuticals info@tiefenbacher.com or visit us on www.tiefenbacher-pharmaceuticals.com

About Tiefenbacher Group – Pioneering Healthcare since 1963

Tiefenbacher Group is a purpose-driven and 100% family-owned healthcare company providing best-in-class solutions along the entire pharmaceutical value chain. From the initial idea to market access of high-quality medicines around the world: We distribute APIs and develop, produce, and register finished dosage forms (FDFs) including highly potent drugs as well as medical devices and e-health solutions. Our purpose is to improve people’s lives by making pharmaceuticals more affordable, more available, and better than ever before.

For further information about TIEFENBACHER GROUP and our solutions for better healthcare and our in-house capabilities to develop and commercialize pharmaceutical products for global markets (including highly potent drugs) please contact us by email info@tiefenbacher.com or visit us on www.tiefenbachergroup.com


State-of-the-art R&D

State-of-the-art R&D facilities for powerful drug development

State-of-the-art R&D facilities for powerful drug development and manufacturing. New technology for generic, valued added, and innovative pharmaceuticals

We, at Tiefenbacher Group, go beyond R&D and manufacturing of pharmaceuticals with a commitment to quality, safety, and reliability that is anchored in everything we do. We continuously expand in novel technologies and capabilities to improve quality and boost productivity for powerful drug developement. Therefore we are pleased to announce that the foundation stone for one of our new Tiefenbacher Laboratories buildings has now been laid.

The new development block “Alfred”, named after the company founder Alfred E. Tiefenbacher, will provide 3360 m². In particularly, the building offers three floors of space for our new product development laboratory, the analysis laboratory, administrative offices and a canteen for employees. Moreover the complex is an important extension to the recently inaugurated development block for highly potent drugs.

This expansion also enables the Tiefenbacher Group to create the best technological conditions and at the same time a high degree of flexibility in the development of generics, value-added products and innovative medicines.

The building will take shape over the next few months and will be ready to be fully operational in about one year.

This investment follows Tiefenbacher Group’s strategy to strengthen its position as a global, fully integrated pharmaceutical company. With Tiefenbacher Laboratories, we own a state-of-the-art R&D and manufacturing site located in Hyderabad, India, for developing and producing high-quality pharmaceuticals including highly potent drugs.

The facilities are equipped with the most modern technologies and software and are subject to the strictest international quality standards. That also includes European (EMA) and US (FDA) approvals. Look forward to more updates on the progress in the coming months.

State-of-the-art R&D

TIEFENBACHER PHARMACEUTICALS, a part of Tiefenbacher Group, develops and commercializes genericvalue added, and innovative pharmaceuticals as well as medical devices and e-health solutions worldwide. We provide over 180+ pharmaceutical products across various therapeutic categories in 10+ dosage forms. With our in-house product development and manufacturing, we can address specific therapeutic needs in unique formulations of prescription drugs (Rx) and over-the-counter (OTC) medicines for global markets.

For more information about our finished dosage forms (FDF) including highly potent drugs and e-health solutions, please contact Tiefenbacher Pharmaceuticals info@tiefenbacher.com or visit us on www.tiefenbacher-pharmaceuticals.com

About Tiefenbacher Group – Pioneering Healthcare since 1963

Tiefenbacher Group is a purpose-driven and 100% family-owned healthcare company providing best-in-class solutions along the entire pharmaceutical value chain. From the initial idea to market access of high-quality medicines around the world: We distribute APIs and develop, produce, and register finished dosage forms (FDFs) including highly potent drugs as well as medical devices and e-health-solutions. Our purpose is to improve people’s lives by making pharmaceuticals more affordable, more available, and better than ever before.

For further information about our solutions for better healthcare and our in-house capabilities to develop and commercialize pharmaceutical products (including highly potent drugs) and e-health-solutions for global markets, please contact us by email at  info@tiefenbacher.com or visit us on:  www.tiefenbacher-group.com


Tiefenbacher Pharmaceuticals Social Day 2023: Community Engagement

TIEFENBACHER PHARMACEUTICALS, a part of Tiefenbacher Group: Social Day 2023 – contribution through our social and community engagement in Hamburg

Tiefenbacher Pharmaceuticals employees get involved in the local community by volunteering with local charities and organizations.
Our employees take an active role in giving back to their communities by donating hours to help through a range of volunteer activities. We see ourselves as part of society and we are deeply committed to supporting the communities in which we are located. That is why we work with our employees to promote a diverse range of social initiatives that help tackle challenges at the local level. In this context, for our Tiefenbacher Group Social Day we have given our employees in hamburg time off so that they can get socially involved in an institution in the Hanseatic city.
We want to promote the common good in our beloved city and therefore supported the Tierpark Hagenbeck (zoo), the Sternbrücke Children’s Hospice, the Stiftung Das Rauhe Haus (child and youth welfare), the alsterdorf assistenz ost (institution for people with disabilities), the Hamburger Tierschutzverein (animal welfare association), and Hanseatic Help e.V. (support for refugees and homeless). Many thanks to all helpers and the organizer Marie-Theres Blumers for your numerous support and the great enthusiasm with which you are committed to your project.

TIEFENBACHER PHARMACEUTICALS, a part of Tiefenbacher Group, develops and commercializes generic, value added, and innovative pharmaceuticals as well as medical devices and e-health solutions worldwide. We provide over 180+ pharmaceutical products across various therapeutic categories in 10+ dosage forms. With our in-house product development and manufacturing, we can address specific therapeutic needs in unique formulations of prescription drugs (Rx) and over-the-counter (OTC) medicines for global markets (including highly potent drugs).
For more information about our finished dosage forms and healthcare solutions, please contact Tiefenbacher Pharmaceuticals: info@tiefenbacher.com or visit us on: www.tiefenbacher-pharmaceuticals.com


Featured Video Play Icon

OYSTA: NEW WEBSITE ONLINE!

OYSTA: New website online – combining pharmaceuticals with e-health technology

We are happy to announce that we have launched a new web page for OYSTA – an innovative healthcare brand which we have developed together with our partner Ondosis.
With OYSTA, we aim to revolutionize the way how patients take their medicines by combining pharmaceuticals with e-health technology to enable intuitive, precise, and flexible dosing. It is a novel treatment approaches for attention deficit hyperactivity disorder (ADHD).
The new web page provides an overview of the purpose, function, and value of the unique product concept. For our community we have already recorded a sneak preview, but see for yourself and learn more about OYSTA on www.oysta-health.com.

 

TIEFENBACHER PHARMACEUTICALS, a part of Tiefenbacher Group, develops and commercializes genericvalue added, and innovative pharmaceuticals as well as medical devices and e-health solutions worldwide. We provide over 180+ pharmaceutical products across various therapeutic categories in 10+ dosage forms. With our in-house product development and manufacturing, we can address specific therapeutic needs in unique formulations of prescription drugs (Rx) and over-the-counter (OTC) medicines for global markets (including highly potent drugs).
For more information about our finished dosage forms and healthcare solutions, please contact Tiefenbacher Pharmaceuticals: info@tiefenbacher.com or visit us on: www.tiefenbacher-pharmaceuticals.com

About Tiefenbacher Group – Pioneering Healthcare since 1963

Tiefenbacher Group is a purpose-driven and 100% family-owned healthcare company providing best-in-class solutions along the entire pharmaceutical value chain. From the initial idea to market access of high-quality medicines around the world: We distribute APIs and develop, produce, and register finished dosage forms (FDF) including highly potent drugs as well as medical devices and e-health-solutions. Our purpose is to improve people’s lives by making pharmaceuticals more affordable, more available, and better than ever before.

For further information about our solutions for better healthcare and our in-house capabilities to develop and commercialize pharmaceutical products (including highly potent drugs) and e-health-solutions for global markets, please contact us by email at info@tiefenbacher.com or visit us on www.tiefenbachergroup.com